| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/07/2013 | WO2013033438A2 Nanoparticle peg modification with h-phosphonates |
| 03/07/2013 | WO2013033400A2 Methods for effectively and rapidly desensitizing allergic patients |
| 03/07/2013 | WO2013033345A1 Immunomodulators and immunomodulator conjugates |
| 03/07/2013 | WO2013033194A1 Levothyroxine formulations |
| 03/07/2013 | WO2013033176A1 Decitabine derivative formulations |
| 03/07/2013 | WO2013032828A2 Method for the preparation of a heat stable oxygen carrier-containing composition facilating beta-beta cross-linking |
| 03/07/2013 | WO2013032643A2 Lipids capable of conformational change and their use in formulations to deliver therapeutic agents to cells |
| 03/07/2013 | WO2013032248A2 Composition for improving skin conditions, containing extracellular domain of human bone morphogenetic protein receptor 1a as active ingredient |
| 03/07/2013 | WO2013032210A2 Biomembrane permeable composition |
| 03/07/2013 | WO2013032207A1 Sustained-release lipid pre-concentrate of pharmacologically active substance and pharmaceutical composition comprising the same |
| 03/07/2013 | WO2013032206A1 Controlled-release oral composition containing itopride hydrochloride, and preparation method thereof |
| 03/07/2013 | WO2013032201A2 Material for preventing adhesion, and method for preventing adhesion |
| 03/07/2013 | WO2013032185A1 Extended release preparation containing pregabalin |
| 03/07/2013 | WO2013032028A1 New compound material, medicine containing same, and cancer treatment method using same |
| 03/07/2013 | WO2013032012A1 Glycosylated polypeptide and drug composition containing said polypeptide |
| 03/07/2013 | WO2013032011A1 Glycosylated polypeptide and drug composition containing said polypeptide |
| 03/07/2013 | WO2013031992A1 Adhesive patch |
| 03/07/2013 | WO2013031972A1 Pump unit of capsule manufacturing apparatus for supplying capsule liquid, capsule manufacturing apparatus applying the pump unit, method for capsule manufacturing applying same, capsule manufactured by same |
| 03/07/2013 | WO2013031949A1 Soft capsule pharmaceutical preparation, composition for soft capsule pharmaceutical preparation, and method for producing soft capsule pharmaceutical preparation |
| 03/07/2013 | WO2013031935A1 Stable pharmaceutical composition |
| 03/07/2013 | WO2013031932A1 P-menthane-3,8-diol isomer mixture, cold-sensitive composition containing same, and product containing said cold-sensitive composition |
| 03/07/2013 | WO2013031882A1 Vaccine preparation for cancer treatment |
| 03/07/2013 | WO2013031833A1 Skin introduction system and lightening agent combining cell introduction peptide and skin introduction accelerator |
| 03/07/2013 | WO2013031022A1 Shellac, taste-improving agent, food, drink and coating composition |
| 03/07/2013 | WO2013030119A1 Dosage form having stabilized active-ingredient particles |
| 03/07/2013 | WO2013029198A1 Adefovir dipivoxil solid formulation and preparation method therefor |
| 03/07/2013 | WO2013029182A1 Stable peptide-based furin inhibitors |
| 03/07/2013 | WO2013029180A1 Stable peptide-based pace4 inhibitors |
| 03/07/2013 | WO2013029139A1 Fluorescent polyaniline nanoparticles |
| 03/07/2013 | WO2012169735A3 Complex comprising water-soluble fragments of fcεri and composition comprising same for treating allergic diseases mediated by ige |
| 03/07/2013 | WO2012160333A3 Recombinant yeast expressing human h- ferritin |
| 03/07/2013 | WO2012148538A3 Anti-endoglin antibodies and knockin mice expressing novel human/mouse chimeric endoglin |
| 03/07/2013 | WO2012141553A3 Stabilizing composition for tetrahydrobiopterin, and method for analyzing tetrahydrobiopterin using same |
| 03/07/2013 | WO2012109363A3 Mucus penetrating gene carriers |
| 03/07/2013 | WO2012057895A9 Composition and method for treating wounds |
| 03/07/2013 | WO2011146852A8 Foams or particles for applications such as drug delivery |
| 03/07/2013 | US20130059928 Method for preparing alkaline hydrolysates of plant proteins |
| 03/07/2013 | US20130059927 Emulsions of Polyisobutenes, Substance and Process |
| 03/07/2013 | US20130059926 Methods for producing biocompatible materials |
| 03/07/2013 | US20130059925 Biodegradable Polymeric Hydrogel Composition |
| 03/07/2013 | US20130059924 Photostabilisers |
| 03/07/2013 | US20130059923 Therapeutic Foam |
| 03/07/2013 | US20130059828 Pharmaceutical composition |
| 03/07/2013 | US20130059795 Novel Composition Of Matter For Delivering Lipid-Soluble Materials, And A Method For Producing It |
| 03/07/2013 | US20130059769 Topically administered, skin-penetrating glycosaminoglycan formulations suitable for use in cosmetic and pharmaceutical applications |
| 03/07/2013 | US20130059006 3-dimensional cardiac fibroblast derived extracellular matrix |
| 03/07/2013 | US20130058985 Spray-Pumpable Composition Suitable for Topical Skin Application |
| 03/07/2013 | US20130058893 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 03/07/2013 | US20130058880 Film forming personal care compositions and methods |
| 03/07/2013 | US20130058875 Capsule having broad color spectrum |
| 03/07/2013 | US20130058869 Prevention And Treatment Of Amyloidogenic Disease |
| 03/07/2013 | DE112009002721T5 Antiemetisches Pflaster Antiemetic patch |
| 03/07/2013 | CA2847336A1 Glycosylated polypeptide and drug composition containing said polypeptide |
| 03/07/2013 | CA2847334A1 Glycosylated polypeptide and drug composition containing said polypeptide |
| 03/07/2013 | CA2847332A1 Vaccine preparation for cancer treatment |
| 03/07/2013 | CA2847218A1 Formulations and dosage forms of oxidized phospholipids |
| 03/07/2013 | CA2846858A1 Methods for effectively and rapidly desensitizing allergic patients |
| 03/07/2013 | CA2846852A1 Fap-activated proteasome inhibitors for treating solid tumors |
| 03/07/2013 | CA2846287A1 Stable peptide-based pace4 inhibitors |
| 03/07/2013 | CA2845851A1 Remote assembly of targeted nanoparticles using h-phosphonate-ene/-yne hydrophosphonylation reactions |
| 03/07/2013 | CA2845845A1 Nanoparticle peg modification with h-phosphonates |
| 03/07/2013 | CA2845784A1 Sustained-release lipid pre-concentrate of pharmacologically active substance and pharmaceutical composition comprising the same |
| 03/07/2013 | CA2845585A1 Decitabine derivative formulations |
| 03/07/2013 | CA2844510A1 Method for the preparation of a heat stable oxygen carrier-containing composition facilitating beta-beta cross-linking |
| 03/06/2013 | EP2564875A1 Liquid preparation for oral administration which can be used in ct colonography, and composition for imaging of digestive tract |
| 03/06/2013 | EP2564874A1 Lyophilized formulation of pectin-adriamycin conjugate and preparation method thereof |
| 03/06/2013 | EP2564873A1 Skin irritation suppressant and transdermal preparation |
| 03/06/2013 | EP2564848A1 Transdermally absorbable donepezil-containing preparation |
| 03/06/2013 | EP2564847A1 Pharmaceutical composition for improving solubility of prasugrel and its preparation method |
| 03/06/2013 | EP2564845A1 Diindolylmethane-based drug for the treatment of hyperplastic and inflammatory diseases |
| 03/06/2013 | EP2564837A1 Enteric tablet |
| 03/06/2013 | EP2564835A1 Fast-dissolving solid pharmaceutical form for treating bacterial infections |
| 03/06/2013 | EP2564834A2 Compounds for Proteasome Enzyme Inhibition |
| 03/06/2013 | EP2564833A1 Photostabilized pharmaceutical composition |
| 03/06/2013 | EP2564830A1 Aqueous composition contained in container |
| 03/06/2013 | EP2563816A1 Anti-icam-1 single domain antibody and uses thereof |
| 03/06/2013 | EP2563809A2 Stable aqueous mia/cd-rap formulations |
| 03/06/2013 | EP2563753A1 Fused cyclooctyne compounds and their use in metal-free click reactions |
| 03/06/2013 | EP2563477A1 Methods and compositions for inducing satiety |
| 03/06/2013 | EP2563406A1 Methods, compositions, and kits for the treatment of matrix mineralization disorders |
| 03/06/2013 | EP2563405A1 Selective integrin inhibitors |
| 03/06/2013 | EP2563404A1 Phospholipid drug analogs |
| 03/06/2013 | EP2563403A1 Conjugated blood coagulation factor viia |
| 03/06/2013 | EP2563402A1 Conjugated blood coagulation factor viii |
| 03/06/2013 | EP2563401A1 Methods for inducing an immune response |
| 03/06/2013 | EP2563400A1 Modified binding proteins inhibiting the vegf-a receptor interaction |
| 03/06/2013 | EP2563399A2 Use of peptides as transporters intended for the internalization of molecules of interest into target cells |
| 03/06/2013 | EP2563396A2 Delivery proteins |
| 03/06/2013 | EP2563361A1 Boosting immune defense by upregulating ccaat/enhancer binding protein epsilon |
| 03/06/2013 | EP2563351A1 Adhesive slow-release formulations for the local administration of curcumin |
| 03/06/2013 | EP2563350A2 Therapeutic regimen and method for treating or ameliorating visual disorders associated with an endogenous retinoid deficiency |
| 03/06/2013 | EP2563349A1 Non-intravenous dosage form comprising solid formulation of liquid biologically active agent and uses thereof |
| 03/06/2013 | EP2563347A2 Propynylaminoindan transdermal compositions |
| 03/06/2013 | EP2563342A1 Indigestible polymer: starch acetate -based film coatings for colon targeting |
| 03/06/2013 | EP2563335A2 Low-oil pharmaceutical emulsion compositions comprising progestogen |
| 03/06/2013 | EP2563334A2 Pharmaceutical emulsion compositions comprising progestogen |
| 03/06/2013 | EP2563332A2 Clay compositions |
| 03/06/2013 | EP2563119A1 Method and medication for prevention and treatment of ocular hypertension and glaucoma |
| 03/06/2013 | EP1792927B1 Novel block copolymer, micelle preparation, and anticancer agent containing the same as active ingredient |
| 03/06/2013 | EP1718283B1 Topical co-enzyme q10 formulations and methods of use |